Androgenetic Alopecia: A Study on The Efficacy of a Combined Protocol of Blue Light Photobiomodulation and Subcutaneous Infiltrations of Biomimetic Peptides
Published: July 19, 2024
Androgenetic
Alopecia
(AGA)
is
a
common
condition
affecting
men
and
women,
characterized
by
progressive
hair
follicle
miniaturization
consequent
loss.
Blue
light
Photobiomodulation
(PBM)
LED
(Light
emitting
diode)
device
infiltrations
of
biomimetic
peptides
therapy
are
two
emerging
approaches
for
AGA
treatment.
The
aim
this
study
was
to
evaluate
the
efficacy
combined
protocol
blue
PBM
on
scalp
A
total
20
patients
with
diagnosis,
according
Hamilton-Norwood
criteria,
were
enrolled
in
study.
All
treated
at
same
time,
both
subcutaneous
scalp.
At
6
months
follow-up,
significant
increase
density
observed
85%
treated.
results
our
suggest
that
PRP
could
be
an
effective
treatment
AGA.
Further
clinical
studies
larger
number
needed
confirm
these
long-term
Language: Английский
The Impact of Growth Factors in Platelet‐Rich Plasma Combination Therapy for Androgenic Alopecia
Jie Ren,
No information about this author
Jingxuan Sun,
No information about this author
Zheng-Hui Li
No information about this author
et al.
Dermatologic Therapy,
Journal Year:
2024,
Volume and Issue:
2024(1)
Published: Jan. 1, 2024
The
efficacy
of
platelet‐rich
plasma
(PRP)
therapy
for
androgenic
alopecia
(AGA)
varies
among
diverse
populations.
While
prior
research
has
emphasized
the
pivotal
role
growth
factors
as
active
components
in
PRP,
specific
relationship
between
and
treatment
outcomes
AGA
remains
unclear.
This
study
aims
to
explore
how
PRP
is
influenced
by
types
concentrations
factors.
analysis
samples
from
46
patients
involved
assessing
seven
using
an
enzyme‐linked
immunosorbent
assay.
Patients
received
a
course
three
treatments
along
with
traditional
medicines.
assessment
conducting
trichoscopy
tests
before
after
treatment,
measuring
both
hair
density
(HD)
caliber
(HC).
findings
revealed
that
HD
increased
36
patients,
positively
correlating
glial
cell‐derived
neurotrophic
factor
(GDNF)
concentration
(
p
=
0.005).
In
addition,
HC
35
demonstrating
positive
correlation
platelet‐derived
factor‐BB
(PDGF‐BB)
<
0.05).
Notably,
gender‐based
identified
statistically
significant
difference
increase
post‐PRP
no
correlations
were
observed
demographic
changes
HD/HC
>
confirms
beneficial
influence
certain
on
outcomes.
Future
should
further
clarify
their
mechanisms
promoting
growth,
paving
way
development
novel
therapeutic
agents.
Language: Английский
Platelet-rich fibrin in dentistry
Ping Song,
No information about this author
Dawei He,
No information about this author
Song Ren
No information about this author
et al.
Journal of Applied Biomaterials & Functional Materials,
Journal Year:
2024,
Volume and Issue:
22
Published: Jan. 1, 2024
Objectives:
To
review
the
progress
of
Platelet
Rich
Fibrin
(PRF)
as
a
biomaterial
in
dentistry
and
to
highlight
its
promising
application
safe
biocompatible
autologous
platelet
concentrate.
Publications
were
searched
GeenMedical,
X-mol,
GoogleScholar,
PubMed
from
October
2024
with
no
language
restrictions.
The
literature
was
for
relevant
databases
journals
on
use
PRFs
up
2024,
inclusion
criteria
included
randomized
controlled
trials,
clinical
case
series,
systematic
reviews.
Conclusion:
PRF
is
second-generation
concentrate
that
sourced
oneself,
has
fewer
adverse
effects,
simple
prepare.
These
materials
include
growth
factors
fibrin
scaffolds,
which
are
extensively
utilized
regenerative
medicine.
By
outlining
PRF,
we
found
good
results
can
be
achieved
when
used
treat
these
conditions.
Clinical
significance:
widespread,
particularly
periodontal
soft
hard
tissue
regeneration,
oral
lichen
planus,
pulpal
regeneration.
This
article
reviews
background,
classification,
preparation
methods
PRFs,
along
their
dental
applications.
We
anticipate
further
research
various
derivatives
future,
will
significantly
improve
utilization
applications
offer
fresh
insights
diagnosing
treating
diseases.
Language: Английский
Evaluation of whole blood immunoreactivity
I A Seledtsova,
No information about this author
Tatyana Ya. Lyubavskaya,
No information about this author
Anatoly Pyshenko
No information about this author
et al.
Pirogov Russian Journal of Surgery,
Journal Year:
2024,
Volume and Issue:
12, P. 122 - 122
Published: Jan. 1, 2024
To
assess
cellular
immunoreactivity,
lipopolysaccharide
(LPS),
Concanavalin
A
(Con
A),
or
LPS
together
with
Con
was
added
to
the
whole
blood
for
18
hours.
preferentially
stimulated
release
of
tumor
necrosis
factor-alfa
(TNF-α),
interleukin-6
(IL-6),
IL-10
and
vascular
endothelial
growth
factor
(VEGF)
by
cells,
whereas
significantly
enhanced
secretion
interferon-gamma
(IFN-gamma)
IL-2.
Addition
heparin
slightly
decreased
IL-2
VEGF,
but
not
other
cytokines.
This
test
can
be
used
innate
adaptive
immunoreactivity
may
useful
in
surgical
practice
preparation
components
(serum,
plasma,
leukocyte-
platelet-rich
plasma)
objective
immunologic
monitoring.
Language: Английский